TGFBR1 and neoplasm: An 18-day topical treatment in a mouse tumor xenograft model demonstrated the successful gene regulation effect of the system, resulting in a 2-fold abolishment of TGFβR-1 expression in tumor tissue and approximately 2.5-fold tumor growth inhibition, in comparison to scrambled siRNA or the PBS-treated control [78].